Comac Medical has successfully completed Phase 1 of Horizon 2020 SME Instrument and has submitted the project report which has been approved by the European Commission.
Horizon 2020 SME Instrument Phase 1 successfully completed
August 27, 2015
Share:
News
Comac Medical is proud to announce the appointment of Peter Windisch as its new Chief Operations Officer (COO).
For small to mid-sized biotech companies, navigating the complexities of clinical trials can be challenging. With limited resources,...
Sofia, November 15th 2024 – Comac Medical is proud to announce the launch of new sustainability initiatives aimed...